Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PHOSPHOROTHIOATE ANTISENSE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 47 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Meunier, L; Monsigny, M; Roche, AC
      Propynylated phosphodiester oligonucleotides inhibit ICAM-1 expression in A549 cells on electroporation

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    2. Ino, H; Chiba, T
      Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo

      JOURNAL OF NEUROSCIENCE
    3. Joyce, GF
      RNA cleavage by the 10-23 DNA enzyme

      RIBONUCLEASES, PT A
    4. Grillone, LR; Lanz, R
      Fomivirsen

      DRUGS OF TODAY
    5. Cantz, T; Ott, M; Kubicka, S; Manns, MP
      Gene therapy and immunotherapy for liver diseases

      INTERNIST
    6. Mishra, M; Porter-Kelley, JM; Singh, PK; Bennett, JR; Chaudhuri, G
      Enhanced activity of antisense phosphorothioate oligos against Leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions

      BIOCHEMICAL PHARMACOLOGY
    7. Mishra, M; Bennett, JR; Chaudhuri, G
      Increased efficacy of antileishmanial antisense phosphorothioate oligonucleotides in Leishmania amazonensis overexpressing ribonuclease H

      BIOCHEMICAL PHARMACOLOGY
    8. Fillion, P; Desjardins, A; Sayasith, K; Lagace, J
      Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides

      BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
    9. Dymock, BW; Jones, PS; Wilson, FX
      Novel approaches to the treatment of hepatitis C virus infection

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    10. Branch, AD
      Hepatitis C virus RNA codes for proteins and replicates: Does it also trigger the interferon response?

      SEMINARS IN LIVER DISEASE
    11. Efferth, T; Fabry, U; Osieka, R
      Leptin contributes to the protection of human leukemic cells from cisplatinum cytoxicity

      ANTICANCER RESEARCH
    12. Giles, RV; Spiller, DG; Tidd, DM
      Chimeric oligodeoxynucleotide analogs: Chemical synthesis, purification, and molecular and cellular biology protocols

      ANTISENSE TECHNOLOGY, PT A
    13. Souvignet, C; Zarski, JP
      Gene therapy approaches in chronic viral hepatitis

      THERAPIE
    14. Atkins, D; Miller, M; De Bouvere, B; van Aerschot, A; Herdewijn, P
      Evaluation of the cellular uptake of hexitol nucleic acids in HeLa cells

      PHARMAZIE
    15. Toyoda, T; Imamura, Y; Takaku, H; Kashiwagi, T; Hara, K; Iwahashi, J; Ohtsu, Y; Tsumura, N; Kato, H; Hamada, N
      Inhibition of influenza virus replication in cultured cells by RNA-cleaving DNA enzyme

      FEBS LETTERS
    16. Walker, MA
      Hepatitis C virus: an overview of current approaches and progress

      DRUG DISCOVERY TODAY
    17. Ruiz, J; Qian, C; Drozdzik, M; Prieto, J
      Gene therapy of viral hepatitis and hepatocellular carcinoma

      JOURNAL OF VIRAL HEPATITIS
    18. Watanabe, N; Sawai, H; Endo, K; Shinozuka, K; Ozaki, H; Tanada, S; Murata, H; Sasaki, Y
      Labeling of phosphorothioate antisense oligonucleotides with yttrium-90

      NUCLEAR MEDICINE AND BIOLOGY
    19. Maurer, N; Mori, A; Palmer, L; Monck, MA; Mok, KWC; Mui, B; Akhong, QF; Cullis, PR
      Lipid-based systems for the intracellular delivery of genetic drugs

      MOLECULAR MEMBRANE BIOLOGY
    20. Blum, HE
      Molecular biology and gene therapy in gastroenterology and hepatology

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    21. Yu, RZ; Geary, RS; Leeds, JM; Watanabe, T; Fitchett, JR; Matson, JE; Mehta, R; Hardee, GR; Templin, MV; Huang, K; Newman, MS; Quinn, Y; Uster, P; Zhu, G; Working, PK; Horner, M; Nelson, J; Levin, AA
      Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of Ha-ras encapsulated in stealth liposomes

      PHARMACEUTICAL RESEARCH
    22. Laktionov, PP; Dazard, JE; Vives, E; Rykova, EY; Piette, J; Vlassov, VV; Lebleu, B
      Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes

      NUCLEIC ACIDS RESEARCH
    23. Chao, Y; Shih, YL; Chen, HJ; Lee, SD; Huang, TS
      Inhibition of DNA synthesis by downregulation of cyclin A but not Skp 2 overexpression in human hepatocellular carcinoma cells

      CANCER LETTERS
    24. Chen, SH; Tzeng, RT
      Polymer solution-filled column for the analysis of antisense phosphorothioates by capillary electrophoresis

      ELECTROPHORESIS
    25. Wagner, H
      Bacterial CpG DNA activates immune cells to signal infectious danger

      ADVANCES IN IMMUNOLOGY, VOL 73
    26. Liang, E; Ajmani, PS; Hughes, JA
      Oligonucleotide delivery: a cellular prospective

      PHARMAZIE
    27. Tao, M; Miyano-Kurosaki, N; Takai, K; Takaku, H
      Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells

      FEBS LETTERS
    28. Kaufman, GD; Shinder, ME; Perachio, AA
      Correlation of Fos expression and circling asymmetry during gerbil Vestibular compensation

      BRAIN RESEARCH
    29. NARUSE K; YAMADA T; SAI XR; HAMAGUCHI M; SOKABE M
      PP125(FAK) IS REQUIRED FOR STRETCH DEPENDENT MORPHOLOGICAL RESPONSE OF ENDOTHELIAL-CELLS

      Oncogene
    30. BORAL AL; DESSAIN S; CHABNER BA
      CLINICAL-EVALUATION OF BIOLOGICALLY TARGETED DRUGS - OBSTACLES AND OPPORTUNITIES

      Cancer chemotherapy and pharmacology
    31. SOKOLOSKI JA; NARAYANAN R; SARTORELLI AC
      ENHANCEMENT BY ANTISENSE OLIGONUCLEOTIDES TO NF-KB OF THE DIFFERENTIATION OF HL-60 PROMYELOCYTIC LEUKEMIA-CELLS INDUCED BY VITAMIN-D-3

      Cancer letters
    32. Wedemeyer, H; Caselmann, WH; Manns, MP
      Combination therapy of chronic hepatitis C: an important step but not the final goal!

      JOURNAL OF HEPATOLOGY
    33. THOMPSON EB
      THE MANY ROLES OF C-MYC IN APOPTOSIS

      Annual review of physiology
    34. ALAHARI SK; DELONG R; FISHER MH; DEAN NM; VILIET P; JULIANO RL
      NOVEL CHEMICALLY-MODIFIED OLIGONUCLEOTIDES PROVIDE POTENT INHIBITION OF P-GLYCOPROTEIN EXPRESSION

      The Journal of pharmacology and experimental therapeutics
    35. BRAND RM; WAHL A; IVERSEN PL
      EFFECTS OF SIZE AND SEQUENCE ON THE IONTOPHORETIC DELIVERY OF OLIGONUCLEOTIDES

      Journal of pharmaceutical sciences
    36. KRONENWETT R; STEIDL U; KIRSCH M; SCZAKIEL G; HAAS R
      OLIGODEOXYRIBONUCLEOTIDE UPTAKE IN PRIMARY HUMAN HEMATOPOIETIC-CELLS IS ENHANCED BY CATIONIC LIPIDS AND DEPENDS ON THE HEMATOPOIETIC-CELL SUBSET

      Blood
    37. ANAZODO MI; DUTA E; SALOMON H; FRIESEN AD; WAINBERG MA; WRIGHT JA
      CHARACTERIZATION OF GPI2A, A POTENT INHIBITOR OF HIV-1 GENE-EXPRESSION AND VIRAL REPLICATION

      Nucleosides & nucleotides
    38. ENJOLRAS N; GODINOT C
      INHIBITION OF UBIQUITOUS MITOCHONDRIAL CREATINE-KINASE EXPRESSION IN HELA-CELLS BY AN ANTISENSE OLIGODEOXYNUCLEOTIDE

      Molecular and cellular biochemistry
    39. ZABNER J
      CATIONIC LIPIDS USED IN GENE-TRANSFER

      Advanced drug delivery reviews
    40. CHRISTOFIDOUSOLOMIDOU M; ALBELDA SM; BENNETT FC; MURPHY GF
      EXPERIMENTAL PRODUCTION AND MODULATION OF HUMAN CYTOTOXIC DERMATITIS IN HUMAN-MURINE CHIMERAS

      The American journal of pathology
    41. GIACHETTI C; CHIN DJ
      INCREASED OLIGONUCLEOTIDE PERMEABILITY IN KERATINOCYTES OF ARTIFICIALSKIN CORRELATES IN DIFFERENTIATION AND ALTERED MEMBRANE-FUNCTION (VOL106, PG 412, 1996)

      Journal of investigative dermatology
    42. TOLOU H; PUGGELLI H; TOCK F; DURAND JP
      PARTIAL INHIBITION OF YELLOW-FEVER VIRUS-REPLICATION IN-VITRO WITH DIFFERENT PHOSPHOROTHIOATE OLIGODEOXYRIBONUCLEOTIDE

      Acta virologica
    43. SAKAKURA C; HAGIWARA A; TSUJIMOTO H; OZAKI K; SAKAKIBARA T; OYAMA T; OGAKI M; IMANISHI T; YAMAZAKI J; TAKAHASHI T
      INHIBITION OF COLON-CANCER CELL-PROLIFERATION BY ANTISENSE OLIGONUCLEOTIDES TARGETING THE MESSENGER-RNA OF THE KI-RAS GENE

      Anti-cancer drugs
    44. ZHANG RW; LU ZH; ZHAO H; ZHANG XS; DIASIO RB; HABUS I; JIANG ZW; IYER RP; YU D; AGRAWAL S
      IN-VIVO STABILITY, DISPOSITION AND METABOLISM OF A HYBRID OLIGONUCLEOTIDE PHOSPHOROTHIOATE IN RATS

      Biochemical pharmacology
    45. ZHANG RW; DIASIO RB; LU ZH; LIU TP; JIANG ZW; GALBRAITH WM; AGRAWAL S
      PHARMACOKINETICS AND TISSUE DISTRIBUTION IN RATS OF AN OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE (GEM-91) DEVELOPED AS A THERAPEUTIC AGENT FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Biochemical pharmacology
    46. GILLARDON F; BECK H; UHLMANN E; HERDEGEN T; SANDKUHLER J; PEYMAN A; ZIMMERMANN M
      INHIBITION OF A C-FOS PROTEIN EXPRESSION IN RAT SPINAL-CORD BY ANTISENSE OLIGODEOXYNUCLEOTIDE SUPERFUSION

      European journal of neuroscience
    47. SCHLINGENSIEPEN KH; SCHLINGENSIEPEN R; KUNST M; KLINGER I; GERDES W; SEIFERT W; BRYSCH W
      OPPOSITE FUNCTIONS OF JUN-B AND C-JUN IN GROWTH-REGULATION AND NEURONAL DIFFERENTIATION

      Developmental genetics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 18:49:01